UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000007194
Receipt number R000008240
Scientific Title Phase II study of 5-FU dose-adjusted mFOLFOX7 plus Bevacizumab for patients with metastatic colorectal cancer(AJUST study)
Date of disclosure of the study information 2012/02/01
Last modified on 2018/09/20 08:23:45

No. Disposal Last modified on Item of update
1 Insert 2012/02/01 16:37:28
2 Update 2012/06/08 10:18:59 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Email1
3 Update 2012/08/29 12:54:29 Email
4 Update 2012/08/29 13:02:12 TEL
5 Update 2012/09/04 20:42:02 Public title
Public title
Acronym
Acronym
6 Update 2012/10/10 14:53:38 Email1
7 Update 2013/02/01 10:07:27 Organization1
Address1
Tel1
Email1
8 Update 2013/09/01 17:18:00 Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
9 Update 2013/09/01 17:54:28 Recruitment status
10 Update 2016/04/04 15:59:18 Address
Address
TEL
Name of primary person or sponsor
Organization
11 Update 2016/11/16 19:45:50 Recruitment status
Publication of results
Results
12 Update 2018/09/20 08:23:45 Recruitment status